Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

By Hermansen K.   Fontaine P.   Kukolja K.   Peterkova V.   Leth G.   Gall M.-A.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 622-629

Springer Publishing Company

Access to resources Recommend Favorite

Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type)

By Vähätalo Markku   Viikari Jorma   Rönnemaa Tapani  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 233-238

Springer Publishing Company

Access to resources Recommend Favorite

HOMA-Estimated Insulin Resistance Is Associated with Hypertension in Iranian Diabetic and Non-Diabetic Subjects

By Esteghamati Alireza   Khalilzadeh Omid   Abbasi Mehrshad   Nakhjavani Manouchehr   Novin Leila   Esteghamati Abdul Reza  

Clinical and Experimental Hypertension, Vol. 30, Iss. 5, 2008-07 ,pp. : 297-307

Informa Healthcare

Access to resources Recommend Favorite

Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance

By Nilsson Peter M.   Hedblad Bo   Donaldson Jill   Berglund Göran  

Blood Pressure, Vol. 16, Iss. 2, 2007-01 ,pp. : 95-100

Informa Healthcare

Access to resources Recommend Favorite

Effects of switching from NPH insulin to insulin glargine in patients with type 2 diabetes: the retrospective, observational LAUREL study in Italy

By Bellia Alfonso   Babini Anna   Marchetto Paolo   Arsenio Leone   Lauro Davide   Lauro Renato  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 269-275

Springer Publishing Company

Access to resources Recommend Favorite